1,2-二甲基-1H-吲哚-3-甲酰氯 | 65610-45-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 1,2-二甲基-1H-吲哚-3-甲酰氯
• 英文名称: 1,2-Dimethyl-1H-indole-3-carbonyl chloride
• 英文别名: 1,2-dimethylindole-3-carboxylic acid chloride；1,2-dimethyl-indole-3-carbonyl chloride；1,2-dimethylindole-3-carbonyl chloride
• CAS: 65610-45-9
• 化学式: C₁₁H₁₀ClNO
• 分子量: 207.659
• InChiKey: QWAYNORAMQALCO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  22
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  1,2-二甲基-1H-吲哚-3-甲酰氯 以86%的产率得到
  参考文献：
  名称：

  BERGMAN J.; CARLSON R.; SJOEBERG B., J. HETEROCYCL. CHEM. , 1977, 14, NO 7, 1123-1134

  摘要：

  DOI：
• 作为产物：
  描述：

  1,2-二甲基吲哚 以85%的产率得到
  参考文献：
  名称：

  BERGMAN J.; CARLSON R.; SJOEBERG B., J. HETEROCYCL. CHEM. , 1977, 14, NO 7, 1123-1134

  摘要：

  DOI：

文献信息

• [EN] INGENOL-3-ACYLATES III AND INGENOL-3-CARBAMATES<br/>[FR] INGÉNOL-3-ACYLATES III ET INGÉNOL-3-CARBAMATES
  申请人：LEO PHARMA AS

  公开号：WO2012083953A1

  公开（公告）日：2012-06-28

  The invention relates to compounds of general formula I wherein R is heteroaryl optionally substituted by R7; or R is heterocycloalkyl or heterocycloalkenyl, optionally substituted by R8; or R is X wherein X is -NR11R12; and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use -alone or in combination with one or more other pharmaceutically active compounds- in therapy, for preventing, treating or ameliorating diseases or conditions responsive to stimulation of neutrophil oxidative burst, responsive to stimulation of keratinocyte IL-8 release or responsive to induction of necrosis.

  该发明涉及一般式I的化合物，其中R为杂环芳基，可选择地由R7取代；或R为杂环烷基或杂环烯基，可选择地由R8取代；或R为X，其中X为-NR11R12；以及其在治疗中的药物可接受的盐、水合物或溶剂合物，用于单独使用或与一个或多个其他药用活性化合物结合在一起，用于预防、治疗或改善对中性粒细胞氧化爆发的刺激响应、对角质细胞IL-8释放的刺激响应或对坏死诱导的刺激响应的疾病或症状。
• INGENOL-3-ACYLATES III AND INGENOL-3-CARBAMATES
  申请人：Grue-Sørensen Gunnar

  公开号：US20140303150A1

  公开（公告）日：2014-10-09

  The invention relates to compounds of general formula I wherein R is heteroaryl optionally substituted by R7; or R is heterocycloalkyl or heterocycloalkenyl, optionally substituted by R8; or R is X wherein X is —NR11R12; and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use—alone or in combination with one or more other pharmaceutically active compounds—in therapy, for preventing, treating or ameliorating diseases or conditions responsive to stimulation of neutrophil oxidative burst, responsive to stimulation of keratinocyte IL-8 release or responsive to induction of necrosis.

  本发明涉及一般式I的化合物，其中R是杂环芳基，可选择由R7取代; 或R是杂环烷基或杂环烯基，可选择由R8取代; 或R是X，其中X是—NR11R12;以及其药学上可接受的盐、水合物或溶剂化物，用于治疗，单独或与一个或多个其他药学活性化合物联合使用，预防、治疗或改善对嗜中性粒细胞氧化爆发刺激、对角质细胞IL-8释放刺激或对坏死诱导反应的疾病或病情的响应。
• Pd-Catalyzed Asymmetric Intramolecular Dearomatizing Reductive Heck Reaction of Indoles
  作者：Bi Wang、Jing-Kun Gao、Shuo Sun、Zhen-Lu Shen、Yun-Fang Yang、Ren-Xiao Liang、Yi-Xia Jia

  DOI：10.1021/acs.orglett.4c00775

  日期：——

  dearomative reductive Heck reaction of N-(o-bromoaryl) indole-3-carboxamide is developed. By employing Pd(dba)2/SPINOL-based phosphoramidite as the chiral catalyst and HCO2Na as the hydride source, a series of enantioenriched spiro indolines bearing vicinal stereocenters were afforded in moderate to good yields with excellent enantioselectivities. The reductive Heck reaction of formal tetrasubstituted

  开发了N- (邻溴芳基)吲哚-3-甲酰胺的对映选择性 Pd 催化分子内脱芳香还原 Heck 反应。通过使用基于Pd(dba) 2 /SPINOL的亚磷酰胺作为手性催化剂和HCO 2 Na作为氢化物源，以中等至良好的产率提供了一系列带有邻位立构中心的对映体富集的螺二氢吲哚，并且具有优异的对映选择性。因此，带有β-氢的形式四取代烯烃的还原Heck反应是通过抑制β-H消除来实现的。
• 2-(Quinuclidin-3-yl)pyrido[4,3-b]indol-1-ones and isoquinolin-1-ones. Potent conformationally restricted 5-HT3 receptor antagonists
  作者：Robin D. Clark、Aaron B. Miller、Jacob Berger、David B. Repke、Klaus K. Weinhardt、Bruce A. Kowalczyk、Richard M. Eglen、Douglas W. Bonhaus、Chi Ho Lee

  DOI：10.1021/jm00070a008

  日期：1993.9

  Several series of N-(quinuclidin-3-yl)aryl and heteroaryl-fused pyridones were synthesized and evaluated for 5-HT3 receptor affinity. In the heteroaryl series, 2-(quinuclidin-3-yl)tetrahydropyrido-[4,3-b]indol-1-one (8a) and the 4,5-alkano-bridged analogues (14 and 15) displayed high 5-HT3 receptor affinity with pK(i) values > 9. The (3S)-quinuclidinyl isomers had > 10 fold higher affinity than the (3R)-isomers. In a series of 2-quinuclidin-3-yl)isoquinolin-1-ones, derivatives substituted with small lipophilic groups (25b-e) and with 4,5-alkano-bridges (34-36) also displayed high affinity. In particular, the hexahydro-1H-benz[de]isoquinolinone (S,S)-37 was the highest affinity 5-HT3 receptor ligand prepared (pK(i) 10.4). A number of the high affinity ligands were shown to be potent 5-HT3 receptor antagonists in vivo as determined by inhibition of the B-J reflex in the anesthetized rat. Again, (S,S)-37 was the most active agent tested (ID50 0.02 mug/kg iv), and this compound was also potent in blocking cisplatin-induced emesis in both the ferret and the dog. Computer modeling studies were performed, and previously reported 5-HT3 receptor antagonist pharmacophore models were refined to include a key lipophilic binding domain.
• Intramolecular Diels-Alder Reactions. 5. Approaches to the Pyrrolo[3,4-c]carbazole and Pyrido[4,3-c]carbazole Systems1
  作者：Engelbert Ciganek、Ernest M. Schubert

  DOI：10.1021/jo00119a046

  日期：1995.7

  Two methods for the preparation of indole-2,3-quinodimethanes are reported. Treatment of 1,2-dimethyl-alpha-oxo-N-(phenylmethyl)-N-2-propenyl-1H-indole-3-acetamide (3) with sodium bis(trimethylsilyl)amide in refluxing THF gave 2-(phenylmethyl)-10c-hydroxy-6-methyl-3,3a,4,5,6,10c-hexahydropyrrolo[3,4-c]-carbazol-1(2H)-one (5) in 18% yield by intramolecular Diels-Alder reaction of the intermediate enolate 4. LiBH4-reduction of amide 3 and thermolysis of the resulting alpha-hydroxyamide 8 at 190 degrees C gave a 63:37 mixture of the cis and trans isomers of 2-(phenylmethyl)-6-methyl-3,3a,4,5,6,10c-hexahydropyrrolo[3,4-c]carbaxol-1(2H)-one (9a and 9b) in 64% yield. The corresponding N-3-butenylamide 10 at 205 degrees C led to a 67:33 mixture of cis- and trans-7-methyl-2,3,4,4a,5,6,7,11c-octahydro-2-(phenylmethyl)-1H-pyrido[4,3-c]carbazol-1-one (11a and 11b) in 53% yield. Thermolysis of 1,2-dimethyl-alpha-hydroxy-N-(phenylmethyl)-N-2-propynyl-1H-indole-3-acetamide (15) gave an equimolar mixture of lactam 9a and the aromatized product, 3,6-dihydro-6-methyl-2-(phenylmethyl)pyrrolo[3,4-c]carbazol-1(2H)-one (17) in 80% yield by disproportionation of the intermediate lactam 16. Reaction of 1,2-dimethyl-1H-indole-3-carboxaldehyde with methyl acrylate and sodium bis(trimethylsilyl)amide produced methyl 1,2-dihydro-9-methyl-9H-carbazole-3-carboxylate (20) in 26% yield, most likely by a sequence of Michael addition to the enolate of the aldehyde and intramolecular aldol condensation.